HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulator of the mucoid phenotype A gene increases the virulent ability of extended-spectrum beta-lactamase-producing serotype non-K1/K2 Klebsiella pneumonia.

AbstractBACKGROUND:
To determine whether the presence of a capsule regulator gene [i.e., regulator of mucoid phenotype A (rmpA) gene] contributes to virulence on extended-spectrum β-lactamase-producing Klebsiella pneumoniae (ESBL-KP) with serotype non-K1/K2 strains.
METHODS:
Twenty-eight ESBL-KP and non-ESBL-KP isolates were collected from the Tri-Service General Hospital (Taipei, Taiwan). The impact of the virulent rmpA gene in different capsular polysaccharide serotypes on ESBL-KP and non-ESBL-KP isolates was studied by a neutrophil phagocytosis reaction, a serum bactericidal assay, and an animal survival model.
RESULTS:
Resistance to broad spectrum antibiotics was more prevalent in ESBL-KP strains than in non-ESBL-KP strains (p < 0.01). The ESBL-KP strains had different molecular patterns from non-ESBL-KP strains, based on pulsed-field gel electrophoresis. The frequency of serum-resistant isolates was the highest among ESBL-KP strains with rmpA (i.e., rmpA(+)) [71.4% (5/7)] than among of non-ESBL-KP rmpA(+) strains [42.8% (6/14)], ESBL-KP strains without rmpA (rmpA(-)) [33.3% (7/21)], and non-ESBL-KP rmpA(-) strains [14.2% (2/14)]. The most significant increase in neutrophil resistance occurred in the ESBL-KP rmpA(+) strains in comparison to the non-ESBL-KP rmpA(+), ESBL-KP rmpA(-), and non-ESBL-KP rmpA(-) strains (p < 0.01). The results of the animal survival model were compatible with the neutrophil phagocytosis reaction and serum bactericidal assay.
CONCLUSION:
We conclude that the pathogenic potential is greater in rmpA(+) ESBL-KP strains than in rmpA(-) ESBL-KP and non-ESBL-KP strains.
AuthorsHsin-An Lin, Ya-Li Huang, Kao-Ming Yeh, L K Siu, Jung-Chung Lin, Feng-Yee Chang
JournalJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi (J Microbiol Immunol Infect) Vol. 49 Issue 4 Pg. 494-501 (Aug 2016) ISSN: 1995-9133 [Electronic] England
PMID25442871 (Publication Type: Journal Article)
CopyrightCopyright © 2014. Published by Elsevier B.V.
Chemical References
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • RmpA protein, Klebsiella pneumoniae
  • beta-Lactamases
Topics
  • Animals
  • Anti-Bacterial Agents (therapeutic use)
  • Bacterial Capsules (genetics)
  • Bacterial Proteins (genetics)
  • Electrophoresis, Gel, Pulsed-Field
  • Humans
  • Klebsiella Infections (drug therapy)
  • Klebsiella pneumoniae (drug effects, genetics, pathogenicity)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neutrophils (immunology)
  • Phagocytosis (genetics, immunology)
  • Serogroup
  • Taiwan
  • beta-Lactamases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: